Robak Oliver, Lakatos Philipp K S, Bojic Andja, Hermann Alexander, Laczika Klaus-Felix, Chiari Astrid, Hiesmayr Jörg M, Staudinger Thomas, Locker Gottfried J
1 Department of Internal Medicine I, Intensive Care Unit, Medical University of Vienna, Vienna - Austria.
Int J Artif Organs. 2014 Nov;37(11):839-46. doi: 10.5301/ijao.5000360. Epub 2014 Oct 28.
Veno-venous extracorporeal membrane oxygenation (vv-ECMO) is pivotal in the treatment of patients suffering from acute respiratory distress syndrome (ARDS). Comparative data with different oxygenator models have not yet been reported. The aim of this retrospective investigation was therefore to assess whether different oxygenator types might influence changing frequency, infection incidence, and mortality in patients on vv-ECMO.
42 patients undergoing vv-ECMO between 1998 and 2009 were identified. In 20 out of these patients, a polypropylene (PP) microporous hollow fiber membrane oxygenator, and in 22 patients a nonmicroporous polymethylpentene (PMP) diffusion membrane oxygenator was used. Infection incidence, changing frequency, and mortality were documented.
In the PMP group, an oxygenator change was necessary less often than in the PP group (p<0.001). The incidence of bacterial, viral, or fungal growth was similar in the groups, thus independent of the frequency of oxygenator change. Irrespective of the groups, the occurrence of Candida sp. tended to correlate with death (p = 0.06). In general, there was a trend towards a higher infection incidence in the subgroup with pulmonary ARDS (p = 0.07). Moreover, infection incidence was associated with a longer ICU stay (p = 0.03) and longer ECMO therapy (p = 0.03). ICU mortality was lower in the PMP group than in the PP group, although not statistically significant (p = 0.10).
The PMP oxygenator membranes showed benefits with regards to changing frequency, but not infection incidence, length of ICU stay, and length of ECMO therapy. There was a trend towards a lower ICU mortality in patients with PMP oxygenators.
静脉-静脉体外膜肺氧合(vv-ECMO)在急性呼吸窘迫综合征(ARDS)患者的治疗中起关键作用。不同氧合器模型的比较数据尚未见报道。因此,本回顾性研究的目的是评估不同类型的氧合器是否会影响接受vv-ECMO治疗患者的更换频率、感染发生率和死亡率。
确定了1998年至2009年间接受vv-ECMO治疗的42例患者。其中20例患者使用聚丙烯(PP)微孔中空纤维膜氧合器,22例患者使用非微孔聚甲基戊烯(PMP)扩散膜氧合器。记录感染发生率、更换频率和死亡率。
在PMP组中,氧合器更换的频率低于PP组(p<0.001)。两组中细菌、病毒或真菌生长的发生率相似,因此与氧合器更换频率无关。无论哪组,念珠菌属的出现都倾向于与死亡相关(p = 0.06)。总体而言,肺ARDS亚组的感染发生率有升高趋势(p = 0.07)。此外,感染发生率与ICU住院时间延长(p = 0.03)和ECMO治疗时间延长(p = 0.03)相关。PMP组的ICU死亡率低于PP组,尽管差异无统计学意义(p = 0.10)。
PMP氧合器膜在更换频率方面显示出优势,但在感染发生率、ICU住院时间和ECMO治疗时间方面没有优势。使用PMP氧合器的患者ICU死亡率有降低趋势。